Furthermore, we observed significantly increased expression levels of anti-PRTN3 IgG and IgM autoantibodies in the early-stage of LUAD, which aligns with the characteristic appearance of autoantibodies during the early-stages of cancer (10). The gene discussed is PRTN3; the disease is cancer.